SHR-A2102 binds nectin-4 on tumor cells, is internalized, and releases a topoisomerase I–inhibitor payload that poisons DNA topoisomerase I, blocking replication and inducing apoptosis. DNA topoisomerase I expression alone does not make cells targets; nectin-4 is the targeting determinant.